Times are displayed in (UTC-05:00) Central Time (US & Canada) Change
5/4/2024 | 11:30 AM – 12:45 PM | Exhibit Hall F1
Poster Session—Novel Immunotherapies for Cancer (AM)
Roles for the chemokine receptor CCR6 in pancreatitis and pancreas cancer
(P127)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 127
Abstract ID: 5421
Presenting Author:
Donovan Drouillard, Med. Col. of Wisconsin
Co-Authors:
Brian Volkman, Med. Col. of Wisconsin; Michael Dwinell, Med. Col. of Wisconsin;
View Abstract Details
Inducible Costimulatory Molecule (ICOS) signaling supports Th17 therapy efficacy
(P129)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 129
Abstract ID: 4101
Presenting Author:
Megen C Wittling, Winship Cancer Inst., Emory Univ.
Co-Authors:
Hannah Knochelmann, Stanford Med.; Anna C Cole, Emory Univ.; Megan M Wyatt, Winship Cancer Inst., Emory Univ.; Ayana T Ruffin, Winship Cancer Inst., Emory Univ.; Soundharya Kumarasan, Emory Univ.; Frances J Bennett, Emory Univ.; Shannon Swisher, Emory Univ.; Chrystal M Paulos, Emory Univ.; Gregory B Lesinski, Emory Univ.;
View Abstract Details
Metabolic modulation unleashes immune vigor in murine pancreas tumors
(P131)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 131
Abstract ID: 5807
Presenting Author:
Maria Poimenidou, Med. Col. of Wisconsin
Co-Authors:
Janet Le, Med. Col. of Wisconsin; Chad Darnell, Univ. of Wisconsin, Milwaukee; Mahmoud AbuEid, Med. Col. of Wisconsin; Donna McAllister, Med. Col. of Wisconsin; Michael Dwinell, Med. Col. of Wisconsin;
View Abstract Details
Non-tumor cell IDO1 non-enzymatically decreases
radiation + PD-1 mAb treatment efficacy in older adults with glioblastoma
(P135)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 135
Abstract ID: 5102
Presenting Author:
Lijie Zhai, Loyola Univ. Chicago
Co-Authors:
April Bell; Evridiki Asimakidou; Kristen Lauing; Derek Wainwright;
View Abstract Details
Targeting RAS/RAF/PI3K pathway for CD40 induction in melanoma cells to overcome resistance to anti-PD1 immunotherapies
(P137)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 137
Abstract ID: 4969
Presenting Author:
Chi Yan, Vanderbilt Univ. Sch. of Med., VA Tennessee Valley Healthcare Sys.
Co-Authors:
Weifeng Luo, Vanderbilt Univ. Sch. of Med.; Sheau-Chiann Chen, Vanderbilt Univ. Med. Ctr.; Douglas B. Johnson, Vanderbilt Univ. Med. Ctr.; Gregory D. Ayers, Vanderbilt Univ. Med. Ctr.; Ann Richmond, Vanderbilt Univ. Sch. of Med.;
View Abstract Details
The next generation DNA vaccine ENO3PEP induces effector T cell responses and promotes anti-tumor immunity in pancreatic cancer.
(P139)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 139
Abstract ID: 4604
Presenting Author:
Silvia Brugiapaglia, Univ. degli Studi di Torino
Co-Authors:
Claudia Curcio, Univ. degli Studi di Torino; Florian Jazaj, Univ. degli Studi di Torino; Demis Grosso, Univ. degli Studi di Torino; Alessandro Scagliotti, Univ. degli Studi di Torino; Rosella Spadi, Univ. degli Studi di Torino; Donata Campra, Univ. degli Studi di Torino; Ennia Dametto, Univ. degli Studi di Torino; Monica Berrino, Univ. degli Studi di Torino; Antonio Amoroso, Univ. degli Studi di Torino; Paola Cappello, Univ. degli Studi di Torino; Francesco Novelli, Univ. degli Studi di Torino;
View Abstract Details
Cryoablation of primary triple-negative breast cancer alters the tumor immune micro-environment in distant tumors.
(P141)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 141
Abstract ID: 5933
Presenting Author:
Flavia Sardela de Miranda, Texas Tech Univ. Hlth. Sci. Ctr.
Co-Authors:
Dalia Martinez-Marin, Texas Tech Univ. Hlth. Sci. Ctr.; Rachel L. Babcock, Texas Tech Univ. Hlth. Sci. Ctr.; Geetha P. Boligala, Texas Tech Univ. Hlth. Sci. Ctr.; Maribel Castro, Texas Tech Univ. Hlth. Sci. Ctr.; Dakota Robison, Texas Tech Univ. Hlth. Sci. Ctr.; Nicholas Wagner, Texas Tech Univ. Hlth. Sci. Ctr.; Sonia Y. Khan, Texas Tech Univ. Hlth. Sci. Ctr.; Karla Daniele, Texas Tech Univ. Hlth. Sci. Ctr.; Kevin Pruitt, Texas Tech Univ. Hlth. Sci. Ctr.; Michael W. Melkus, Texas Tech Univ. Hlth. Sci. Ctr.; Rakhshanda Layeequr Rahman, Texas Tech Univ. Hlth. Sci. Ctr.;
View Abstract Details
Using gilteritinib and the mammalian target of rapamycin (mTOR) inhibitors to target FLT3 signaling as a treatment for FLT3+ Acute Myeloid Leukemia patients.
(P143)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 143
Abstract ID: 4478
Presenting Author:
Malia E Leifheit, Rush Univ.
Co-Authors:
Gunnar Johnson, Rush Univ.; Hyun Yun, Rush Univ.; Kajal Gupta, Rush Univ.; Amanda L Marzo, Rush Univ.;
View Abstract Details
T cell immune landscape in melanoma patients before and post immune checkpoint blockade treatment
(P145)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 145
Abstract ID: 4821
Presenting Author:
Ying Luo, Univ. of Texas Southwestern Med. Ctr.
Co-Authors:
Chen Yao, Univ. of Texas Southwestern Med. Ctr.; Tuoqi Wu, Univ. of Texas Southwestern Med. Ctr.;
View Abstract Details
PD-1 endocytosis unleashes the cytolytic potential of check-point blockade in tumor immunity
(P149)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 149
Abstract ID: 6071
Presenting Author:
Andres Oroya, Hosp. Maisonneuve-Rosemont, University de Montréal (University of Montreal)
Co-Authors:
Elham Ben Saad, Hosp. Maisonneuve-Rosemont; Meriem Bachais, Hosp. Maisonneuve-Rosemont; Christopher Rudd, Hosp. Maisonneuve-Rosemont;
View Abstract Details
Gemcitabine improves tumor antigen presentation in pancreatic cancer.
(P151)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 151
Abstract ID: 5387
Presenting Author:
Alaina C Larson, Univ. of Nebraska Med. Ctr.
Co-Authors:
Gabrielle Brumfield, Univ. of Nebraska Med. Ctr.; Kenadie Doty, Univ. of Nebraska Med. Ctr.; Promise Moore-Saufley, Univ. of Nebraska, Omaha;
View Abstract Details
Evaluating fenbendazole's cytotoxic impact on malignant cell viability
(P153)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 153
Abstract ID: 4811
Presenting Author:
Phalak Dhingra, Western Reserve Acad.
Co-Author:
Robert Aguilar, Western Reserve Acad.;
View Abstract Details
Examining the antitumorigenic effects of Ruminococcus gnavus
(P155)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 155
Abstract ID: 5091
Presenting Author:
Colin Laughlin, Univ. of Pittsburgh Sch. of Med.
Co-Authors:
Alex McPherson, Univ. of Pittsburgh Sch. of Med.; Surya Pandey, Univ. of Pittsburgh Sch. of Med.; Jake Shapira, Univ. of Pittsburgh Sch. of Med.; Catherine Phelps, Univ. of Pittsburgh Sch. of Med.; Amanda Lee, Univ. of Pittsburgh Sch. of Med.; Simran Randhawa, Univ. of Pittsburgh Sch. of Med.; Rachel Gottschalk, Univ. of Pittsburgh Sch. of Med.; Zhen Yang, Carnegie Mellon Univ.; Reinhard Hinterleitner, Univ. of Pittsburgh Sch. of Med.; Marlies Meisel, Univ. of Pittsburgh Sch. of Med.;
View Abstract Details
A novel discovery platform that establishes stable terminal dysfunction in human CAR T cells
(P159)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 159
Abstract ID: 4374
Presenting Author:
Abbey A Saadey, Ohio State Univ. Col. of Med.
Co-Authors:
Amir Yousif, Ohio State Univ. Col. of Med.; Ava Lowin, Ohio State Univ. Col. of Med.; Chelsea Castillo, Ohio State Univ. Col. of Med.; Wing Keung Chan, Ohio State Univ. Comp. Cancer Ctr.; Sumithira Vasu, Ohio State Univ. Comp. Cancer Ctr.; Marcos J de Lima, Ohio State Univ. Comp. Cancer Ctr.; Lapo Alinari, Ohio State Univ. Comp. Cancer Ctr.; Hazem E Ghoneim, Ohio State Univ. Col. of Med.;
View Abstract Details
Evaluation of combination mTOR agonist and CD147-IL15-CAR-NK cell therapy in transgenic human CD147 Hepatocellular Carcinoma models
(P161)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 161
Abstract ID: 4477
Presenting Author:
Minh Ma, Rutgers New Jersey Med. Sch., Rutgers Grad. Sch. of Biomed. Sci.
Co-Authors:
Kristy Fu, Rutgers New Jersey Med. Sch.; Maeve Byrne, Rutgers New Jersey Med. Sch.; Sajjan Rajpoot, Rutgers New Jersey Med. Sch.; Jong Hyun Cho, Rutgers New Jersey Med. Sch.; Sushil Tripathi, Rutgers New Jersey Med. Sch.; Jianliang Shen, Rutgers Cancer Inst. of New Jersey; Wei-Xing Zong, Rutgers Cancer Inst. of New Jersey; Dongfang Liu, Rutgers New Jersey Med. Sch.;
View Abstract Details
Sensitizing solid tumors to perforin-independent CAR T-cell killing
(P163)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 163
Abstract ID: 5265
Presenting Author:
Matthew C Guttormson, Mayo Clin. Grad. Sch. of Biomed. Sci.
View Abstract Details
β-adrenergic signaling regulates erythropoiesis and through it; cancer immunity
(P165)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 165
Abstract ID: 5658
Presenting Author:
Arshmeet K Chawla, UConn Hlth.
Co-Authors:
Adam T Hagymasi, UConn Hlth.; Rory J Geyer, UConn Hlth.; Ion I Mandoiu, UConn; Kenneth R Peterson, Univ. of Kansas Med. Ctr.; Vanessa M Scanlon, UConn Hlth.; Pramod K Srivastava, UConn Hlth.; James T Nevin, UConn Hlth.;
View Abstract Details
ER-Golgi Network Regulates Anti-Tumor T Cell Immunotherapeutic Response
(P167)Presentation Time: 11:30 AM–12:45 PM
Posterboard Number: 167
Abstract ID: 6045
Presenting Author:
Nathaniel Oberholtzer, Med. Univ. of South Carolina
Co-Authors:
Paramita Chakraborty, Med. Univ. of South Carolina; Mohamed Faisal Kassir, Med. Univ. of South Carolina; Stephanie Mills; Susana Comte-Walters, Med. Univ. of South Carolina; Monika Gooz; Zacharia Hedley, Med. Univ. of South Carolina; Silvia Vaena, Med. Univ. of South Carolina; Martin Romeo, Med. Univ. of South Carolina; Stefano Berto, Med. Univ. of South Carolina; Reid DeMass, Med. Univ. of South Carolina; Gina Scurti, Med. Univ. of South Carolina; Elizabeth Hill, Med. Univ. of South Carolina; Lauren Ball, Med. Univ. of South Carolina; Eduardo Maldonado, Med. Univ. of South Carolina; Michael Nishimura, Med. Univ. of South Carolina; Besim Ogretmen, Med. Univ. of South Carolina; Shikhar Mehrotra, Med. Univ. of South Carolina;
View Abstract Details